SCHEMBL6108906

SCHEMBL6108906

Cc1cc(N2CCC(N(C)c3ccccc3C(=O)Nc3ncccc3Cl)CC2)ccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ F10 P00742 2/20 0.41
▸ F2 P00734 1/20 0.41
▸ PLAT P00750 1/20 0.41
▸ KLKB1 P03952 1/20 0.41
▸ BDKRB1 P46663 5/20 0.41
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ WDR5 P61964 1/20 0.38
▸ LDHA P00338 1/20 0.38
▸ MALT1 Q9UDY8 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ ALK Q9UM73 1/20 0.37
▸ SMO Q99835 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607911 0.83 NPC1 (0.48) F10F2PLATKLKB1KMT2A
SCHEMBL6108909 0.81 F10 (0.47) ALDH1A1F10BDKRB1LDHA
SCHEMBL6717550 0.73 F10 (0.45) F10KMT2AMEN1RAB9ANPC1
SCHEMBL6108431 0.73 F10 (0.45) F10RAB9ANPC1
SCHEMBL6109172 0.72 USP30 (0.45) F10RAB9ANPC1
SCHEMBL6107816 0.72 NPC1 (0.49) F10BDKRB1KMT2AMEN1RAB9A
SCHEMBL6107341 0.72 F10 (0.43) F10RAB9ANPC1
SCHEMBL7016107 0.71 JAK2 (0.50) F10F2PLATKLKB1LDHA
Trifluoroacetic Acid SCHEMBL6108697 0.69 F10 (0.45) F10KMT2AMEN1RAB9ANPC1
SCHEMBL784478 0.69 ALDH1A1 (0.41) ALDH1A1F10F2PLATKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129245-B2 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots ELI LILLY AND COMPANY (US) 2006-10-31 — — US disclosed
Send feedback